N-3 Fatty acids affect haemostasis but do not increase the risk of bleeding: Clinical observations and mechanistic insights

British Journal of Nutrition

Volumn 111, Issue 9, 2014, Pages 1652-1662

  Wachira, John K ^a   Larson, Mark K ^b   Harris, William S ^a,c,d  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b AUGUSTANA COLLEGE   (United States)

^c Health Diagnostic Laboratory Inc   (United States)

^d OmegaQuant Analytics   (United States)

Author keywords

Bleeding; DHA; EPA; Fish oil; Haemostasis; n 3 Fatty acids; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BEZAFIBRATE; CLOPIDOGREL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LOW MOLECULAR WEIGHT HEPARIN; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; PLACEBO; PRAVASTATIN; PROSTAGLANDIN SYNTHASE; SIMVASTATIN; WARFARIN;

ABDOMINAL SURGERY; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD CLOTTING; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN VASOSPASM; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC PERIODONTITIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DRUG MEGADOSE; EPISTAXIS; FIBRINOLYTIC THERAPY; GINGIVA BLEEDING; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMOSTASIS; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; INTENSIVE CARE; KIDNEY HEMORRHAGE; LOADING DRUG DOSE; LOW DRUG DOSE; MONOTHERAPY; OPERATIVE BLOOD LOSS; PARENTERAL NUTRITION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION ASSAY; POSTOPERATIVE HEMORRHAGE; PREGNANCY OUTCOME; RECTUM HEMORRHAGE; RESTENOSIS; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; SPINAL CORD DECOMPRESSION; STABLE ANGINA PECTORIS; SUBARACHNOID HEMORRHAGE; SUBCUTANEOUS HEMORRHAGE; THROMBOCYTE AGGREGATION; VAGINA BLEEDING;

DIETARY FATS; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FATTY ACIDS, OMEGA-3; FISH OILS; HEMORRHAGE; HEMOSTASIS; HUMANS; HYPOLIPIDEMIC AGENTS; MODELS, BIOLOGICAL; RISK;

EID: 84898008385     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451300425X     Document Type: Article

References (88)

1. Dyerberg J & Bang HO (1979) Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet ii, 433-435
2. Dyerberg J, Bang HO, Stoffersen E, et al. (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet ii, 117-119
3. Parkinson AJ, Cruz AL, Heyward WL, et al. (1994) Elevated concentrations of plasma omega-3 polyunsaturated fatty acids among Alaskan Eskimos. Am J Clin Nutr 59, 384-388
4. Knapp HR (1997) Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 65, Suppl., 1687S-1698S.
5. Harris WS (2007) Expert opinion: Omega-3 fatty acids and bleeding - cause for concern?. Am J Cardiol 99, S44-S46
6. Eritsland J, Arnesen H, Seljeflot I, et al. (1995) Long-Term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis 6, 17-22
7. Gajos G, Rostoff P, Undas A, et al. (2010) Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The OMEGA-PCI (OMEGA-3 fatty acids after PCI to modify responsiveness to dual antiplatelet therapy) study. J Am Coll Cardiol 55, 1671-1678
8. Gajos G, Zalewski J, Rostoff P, et al. (2011) Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI Clot). Arterioscler Thromb Vasc Biol 31, 1696-1702
9. Gajos G, Zalewski J, Nessler J, et al. (2012) Polyunsaturated omega-3 fatty acids improve responsiveness to clopidogrel after percutaneous coronary intervention in patients with cytochrome P450 2C19 loss-of-function polymorphism. Kardiol Pol 70, 439-445
10. Iacoviello L, Amore C, De CA, et al. (1992) Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids. Arterioscler Thromb 12, 1191-1197
11. Cairns J, Gill J, Morton B, et al. (1996) Fish oils and lowmolecular weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation 94, 1553-1560
12. Yokoyama M, Origasa H, Matsuzaki M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 369, 1090-1098
13. Tanaka K, Ishikawa Y, Yokoyama M, et al. (2008) Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: Subanalysis of the JELIS trial. Stroke 39, 2052-2058
14. Cohen MG, Rossi JS, Garbarino J, et al. (2011) Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: Beyond aspirin and clopidogrel. Thromb Res 128, 335-340
15. Nilsen DW, Dalaker K, Nordoy A, et al. (1991) Influence of a concentrated ethylester compound of n-3 fatty acids on lipids, platelets and coagulation in patients undergoing coronary bypass surgery. Thromb Haemost 66, 195-201
16. Watson PD, Joy PS, Nkonde C, et al. (2009) Comparison of bleeding complications with omega-3 fatty acids ' aspirin ' clopidogrel - versus - Aspirin ' clopidogrel in patients with cardiovascular disease. Am J Cardiol 104, 1052-1054
17. Park Y, Park S, Yi H, et al. (2009) Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res 29, 825-830
18. Salisbury AC, Harris WS, Amin AP, et al. (2012) Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction. Am J Cardiol 109, 13-18
19. Harris WS & von Schacky C (2004) The Omega-3 Index: A new risk factor for death from coronary heart disease?. Prev Med 39, 212-220
20. Yoneda H, Shirao S, Kurokawa T, et al. (2008) Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage?. Acta Neurol Scand 118, 54-59
21. Lok CE, Moist L, Hemmelgarn BR, et al. (2012) Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: A randomized controlled trial. JAMA 307, 1809-1816
22. Ferraro PM, Ferraccioli GF, Gambaro G, et al. (2009) Combined treatment with renin-Angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial. Nephrol Dial Transplant 24, 156-160
23. Martin JM & Stapleton RD (2010) Omega-3 fatty acids in critical illness. Nutr Rev 68, 531-541
24. Friesecke S, Lotze C, Kohler J, et al. (2008) Fish oil supplementation in the parenteral nutrition of critically ill medical patients: A randomised controlled trial. Intensive Care Med 34, 1411-1420
25. Kepler CK, Huang RC, Meredith D, et al. (2012) Omega-3 and fish oil supplements do not cause increased bleeding during spinal decompression surgery. J Spinal Disord Tech 25, 129-132
26. Meredith DS, Kepler CK, Hirsch B, et al. (2012) The effect of omega-3 fatty-Acid supplements on perioperative bleeding following posterior spinal arthrodesis. Eur Spine J 21, 2659-2663
27. Katan MB, Deslypere JP, van Birgelen AP, et al. (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: An 18-month controlled study. J Lipid Res 38, 2012-2022
28. Heller AR, Fischer S, Rossel T, et al. (2002) Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr 87, Suppl. 1, S95-S101
29. GISSI-HF Investigators, Tavazzi L, Maggioni AP, et al. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 372, 1223-1230
30. Calo L, Bianconi L, Colivicchi F, et al. (2005) N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized, controlled trial. J Am Coll Cardiol 45, 1723-1728
31. Mozaffarian D, Marchioli R, Macchia A, et al. (2012) Fish oil and postoperative atrial fibrillation: The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 308, 2001-2011
32. Krysiak R & Okopien B (2012) Hemostatic effects of omega-3 fatty acids in isolated hypertriglyceridemic patients treated with bezafibrate. Eur J Intern Med 23, e168-e169
33. Daak AA, Ghebremeskel K, Hassan Z, et al. (2013) Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: Randomized, double-blind, placebocontrolled trial. Am J Clin Nutr 97, 37-44
34. Olsen SF & Joensen HD (1985) High liveborn birth weights in the Faroes: A comparison between birth weights in the Faroes and in Denmark. J Epidemiol Community Health 39, 27-32
35. Olsen SF, Secher NJ, Tabor A, et al. (2000) Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 107, 382-395
36. Elkhouli AM (2011) The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study). J Periodontal Res 46, 261-268
37. Mozaffarian D & Wu JHY (2011) Omega-3 fatty acids and cardiovascular disease: Ffects on risk factors, molecular pathways and clinical events. J Am Coll Cardiol 58, 2047-2067
38. He K, Song Y, Daviglus ML, et al. (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: A meta-Analysis of cohort studies. Circulation 109, 2705-2711
39. Marchioli R, Barzi F, Bomba E, et al. (2002) Early protection against sudden Death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105, 1897-1903
40. Gao LG, Cao J, Mao QX, et al. (2013) Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: A meta-Analysis of randomized controlled trials. Atherosclerosis 226, 328-334
41. Thorngren M & Gustafson A (1981) Effects of 11-week increases in Dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet ii, 1190-1193
42. Lorenz R, Spengler U, Fischer S, et al. (1983) Platelet function, thromboxane formation and blood pressure control during supplementation of the Western Diet with cod liver oil. Circulation 67, 504-511
43. Haines AP, Sanders TA, Imeson JD, et al. (1986) Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics. Thromb Res 43, 643-655
44. Gibney MJ & Bolton-Smith C (1988) The effect of a dietary supplement of n-3 polyunsaturated fat on platelet lipid composition, platelet function and platelet plasma membrane fluidity in healthy volunteers. Br J Nutr 60, 5-12
45. Harris WS, Silveira S & Dujovne CA (1990) The combined effects of N-3 fatty acids and aspirin on hemostatic parameters in man. Thromb Res 57, 517-526
46. Driss F, Vericel E, Lagarde M, et al. (1984) Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res 36, 389-396
47. Dona M, Fredman G, Schwab JM, et al. (2008) Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848-855
48. Fredman G, Van Dyke TE & Serhan CN (2010) Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol 30, 2005-2013
49. Chen P, Vericel E, Lagarde M, et al. (2011) Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J 25, 382-388
50. Lagarde M, Calzada C, Guichardant M, et al. (2013) Doseeffect and metabolism of docosahexaenoic acid: Pathophysiological relevance in blood platelets. Prostaglandins Leukot Essent Fatty Acids 88, 49-52
51. Kinsella JE, Lokesh B & Stone RA (1990) Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: Possible mechanisms. Am J Clin Nutr 52, 1-28
52. Siess W, Roth P, Scherer B, et al. (1980) Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation During a mackerel diet. Lancet i, 441-444
53. Bradlow BA, Chetty N, van Der Westhuyzen J, et al. (1983) The effects of a mixed fish diet on platelet function, fatty acids and serum lipids. Thromb Res 29, 561-568
54. Santos MT, Valles J, Aznar J, et al. (2006) Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease. J Lab Clin Med 147, 220-227
55. Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927-929
56. Dyszkiewicz-Korpanty AM, Frenkel EP & Sarode R (2005) Approach to the assessment of platelet function: Comparison between optical-based platelet-rich plasma and impedancebased whole blood platelet aggregation methods. Clin Appl Thromb Hemost 11, 25-35
57. George JN, Caen JP & Nurden AT (1990) Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood 75, 1383-1395
58. Burgess-Wilson ME, Cockbill SR, Johnston GI, et al. (1987) Platelet aggregation in whole blood from patients with Glanzmann's thrombasthenia. Blood 69, 38-42
59. Bennett JS, Hoxie JA, Leitman SF, et al. (1983) Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci U S A 80, 2417-2421
60. Needleman P, Whitaker MO, Wyche A, et al. (1980) Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: Pharmacological basis for a therapeutic approach. Prostaglandins 19, 165-181
61. Brox JH, Killie JE, Osterud B, et al. (1983) Effects of cod liver oil on platelets and coagulation in familial hypercholesterolemia (type IIa). Acta Med Scand 213, 137-144
62. von Schacky C, Fischer S & Weber PC (1985) Long-Term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 76, 1626-1631
63. Swann PG, Venton DL & Le Breton GC (1989) Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett 243, 244-246
64. Swann PG, Parent CA, Croset M, et al. (1990) Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. J Biol Chem 265, 21692-21697
65. Wada M, DeLong CJ, Hong YH, et al. (2007) Enzymes and receptors of prostaglandin pathways with arachidonic acidderived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 282, 22254-22266
66. Larson MK, Ashmore JH, Harris KA, et al. (2008) Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb Haemost 100, 634-641
67. Needleman P, Raz A, Minkes MS, et al. (1979) Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A 76, 944-948
68. Whitaker MO, Wyche A, Fitzpatrick F, et al. (1979) Triene prostaglandins: Prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances. Proc Natl Acad Sci U S A 76, 5919-5923
69. Boukhchache D & Lagarde M (1982) Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta 713, 386-392
70. Morita I, Takahashi R, Saito Y, et al. (1983) Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid. J Biol Chem 258, 10197-10199
71. Larson MK, Shearer GC, Ashmore JH, et al. (2011) Omega-3 fatty acids modulate collagen signaling in human platelets. Prostaglandins Leukot Essent Fatty Acids 84, 93-98
72. Guillot N, Caillet E, Laville M, et al. (2009) Increasing intakes of the long-chain omega-3 docosahexaenoic acid: Ffects on platelet functions and redox status in healthy men. FASEB J 23, 2909-2916
73. Li XL & Steiner M (1990) Fish oil: A potent inhibitor of platelet adhesiveness. Blood 76, 938-945
74. Li XL & Steiner M (1991) Dose response of dietary fish oil supplementations on platelet adhesion. Arterioscler Thromb 11, 39-46
75. Del Turco S, Basta G, Lazzerini G, et al. (2008) Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction. Haematologica 93, 892-899
76. Phang M, Lincz L, Seldon M, et al. (2012) Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects. J Nutr Biochem 23, 1128-1133
77. Harker LA, Kelly AB, Hanson SR, et al. (1993) Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 87, 1017-1029
78. Jerling JC, Curiel-Martos A, Kroner C, et al. (2003) Fish oil inhibits photochemically induced thrombosis in the guinea pig in a dose dependent manner. Thromb Res 111, 11-17
79. Braden GA, Knapp HR, Fitzgerald DJ, et al. (1990) Dietary fish oil accelerates the response to coronary thrombolysis with tissue-Type plasminogen activator: Evidence for a modest platelet inhibitory effect in vivo. Circulation 82, 178-187
80. Aarsetoy H, Brugger-Andersen T, Hetland O, et al. (2006) Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-Associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction. Thromb Haemost 95, 329-336
81. Din JN, Harding SA, Valerio CJ, et al. (2008) Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 197, 290-296
82. Moertl D, Berger R, Hammer A, et al. (2011) Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure. Thromb Haemost 106, 457-465
83. Monroe DM, Hoffman M & Roberts HR (2002) Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22, 1381-1389
84. Tracy PB, Nesheim ME & Mann KG (1981) Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J Biol Chem 256, 743-751
85. Vanschoonbeek K, Feijge MA, Paquay M, et al. (2004) Variable hypocoagulant effect of fish oil intake in humans: Modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 24, 1734-1740
86. Larson MK, Tormoen GW, Weaver LJ, et al. (2013) Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation. Am J Physiol Cell Physiol 304, C273-C279
87. de Roos B, Mavrommatis Y & Brouwer IA (2009) Long-chain n-3 polyunsaturated fatty acids: New insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol 158, 413-428
88. Xiong JP, Stehle T, Diefenbach B, et al. (2001) Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294, 339-345